Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245.6 EUR | -0.14% | -.--% | -.--% |
01:58pm | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Apr. 25 | The specter of stagflation rears its ugly head again |
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock
- News Roche Holding AG